← back to search

Susanne Dudman

Oslo University Hospital · NO
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Viral gastroenteritis research and epidemiology, Respiratory viral infections research, COVID-19 Clinical Research Studies, and Viral Infections and Immunology Research.
h-index
35
citations
5,836
works
143
NIH funding
primary concept
Medicine
email

Recent publications

Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial.
2026cited by 0position: contributordoi
Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group.
2025cited by 12position: contributordoi
Epidemiological and Clinical Insights into Enterovirus Circulation in Europe, 2018-2023: A Multicenter Retrospective Surveillance Study.
2025cited by 9position: contributordoi
Sustained circulation of enterovirus D68 in Europe in 2023 and the continued evolution of enterovirus D68 B3-lineages associated with distinct amino acid substitutions in VP1 protein.
2025cited by 6position: contributordoi
Global hepatitis C elimination: Updates, challenges, and opportunities from real-world experiences in Europe and North America.
2025cited by 1position: contributordoi
Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?
2025cited by 1position: contributordoi
Cellular and Humoral Immune Profiles After Hepatitis E Vaccination and Infection.
2025cited by 0position: contributordoi
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021–2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study
The Journal of Infectious Diseases 2024cited by 29position: middledoi
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study.
2024cited by 27position: contributordoi
Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial.
2024cited by 16position: contributordoi
Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial.
2024cited by 14position: contributordoi
Long Covid: a global health issue - a prospective, cohort study set in four continents.
2024cited by 13position: contributordoi
Parechovirus A Circulation and Testing Capacities in Europe, 2015-2021.
2024cited by 8position: contributordoi
Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study.
2024cited by 6position: contributordoi
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
2024cited by 6position: contributordoi
Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study.
2024cited by 4position: contributordoi
Clinical Evaluation of the VirClia IgM/IgG Chemiluminescence Tests for the Diagnosis of Tick-Borne Encephalitis in an Endemic Part of Norway.
2024cited by 2position: contributordoi
Tracing the adaptive evolution of SARS-CoV-2 during vaccine roll-out in Norway.
2024cited by 2position: contributordoi
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
2024cited by 1position: contributordoi
Hepatitis E vaccine and fetal loss: the potential pathophysiological basis - Authors' reply.
2024cited by 0position: contributordoi
A second update on mapping the human genetic architecture of COVID-19.
2023cited by 92position: contributordoi
Neurological manifestations of COVID-19 in adults and children.
2023cited by 54position: contributordoi
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
2023cited by 50position: contributordoi
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
2023cited by 14position: contributordoi
Circulating markers of extracellular matrix remodelling in severe COVID-19 patients.
2023cited by 13position: contributordoi
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
2023cited by 9position: contributordoi
Antibiotic Consumption in a Cohort of Hospitalized Adults with Viral Respiratory Tract Infection.
2023cited by 8position: contributordoi
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
2023cited by 3position: contributordoi
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
2023cited by 2position: contributordoi
Detailed stratified GWAS analysis for severe COVID-19 in four European populations.
2022cited by 80position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Thea Kølsen Fischer · Universitetshospitalernes Center for Sundhedsfaglig Forskning10 papers (2019–2025)Kimberley S M Benschop · National Institute for Public Health and the Environment8 papers (2019–2025)Bente Halvorsen · Harvard University7 papers (2020–2025)Heli Harvala · NHS Blood and Transplant6 papers (2020–2025)Saye Khoo · University of Liverpool4 papers (2023–2024)Vanessa Sancho-Shimizu · Johns Hopkins Hospital4 papers (2023–2024)Ewen M. Harrison · Johns Hopkins Hospital4 papers (2023–2024)Peter Horby · Johns Hopkins Hospital4 papers (2023–2024)Nicolas Terzi · Johns Hopkins Hospital3 papers (2023–2024)Agnès Sommet · French Clinical Research Infrastructure Network3 papers (2023–2024)Robert Fowler · Sunnybrook Health Science Centre3 papers (2023–2024)Janet T Scott · Montreal Heart Institute3 papers (2023–2024)Wendy Barclay · Johns Hopkins Hospital3 papers (2023–2024)Alexander J. Mentzer · Moscow Institute of Thermal Technology3 papers (2023–2024)Alistair Nichol · St. James's Hospital3 papers (2023–2024)Dominique Deplanque · Inserm3 papers (2023–2024)Charlotte Summers · University of Sheffield3 papers (2023–2024)Srinivas Murthy · University of Bari Aldo Moro3 papers (2023–2024)Luis Felipe Reyes · Johns Hopkins Hospital3 papers (2023–2024)Wei Shen Lim · Nottingham University Hospitals NHS Trust3 papers (2023–2024)